# A Study of Enzastaurin in Patients With Leukemia

> **NCT00452257** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 18 (actual)

## Conditions studied

- Leukemia, Lymphocytic

## Interventions

- **DRUG:** enzastaurin

## Key facts

- **NCT ID:** NCT00452257
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2009-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00452257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00452257, "A Study of Enzastaurin in Patients With Leukemia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00452257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*